Optimizing Treatment with Cabergoline 0.25 mg for Prolactinomas
IntroductionCabergoline 0.25 mg is a dopamine agonist with extensive applications in the management of hyperprolactinemia (high prolactin levels) and prolactinomas (pituitary tumors secreting excess prolactin). Cabergoline 0.25 mg, with its long half-life and...
0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
Διαφημίσεις